OSR Health reported revenue of $0.32M and net income of -$4.16M for the quarter ended Jun 2026, down 72.2% year over year. This income statement covers 18 quarters of results from Dec 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2021 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||||
| Revenue | 0.91M | 0.88M | 0.82M | 0.92M | 0.76M | 1.14M | 0.63M | 0.38M | 0.48M | 0.32M | ||||||||
| Cost of RevenueCost of Rev | 0.67M | 0.65M | 0.64M | 0.76M | 0.59M | 1.10M | 0.37M | 0.25M | 0.32M | 0.23M | ||||||||
| Gross Profit | 0.24M | 0.23M | 0.18M | 0.16M | 0.17M | 0.03M | 0.26M | 0.13M | 0.16M | 0.09M | ||||||||
| Operating items | ||||||||||||||||||
| Amortization - Intangibles | 2.90M | 2.78M | 2.82M | 2.27M | 2.35M | 2.39M | ||||||||||||
| Research & DevelopmentR&D | 0.05M | 0.05M | 0.05M | 0.09M | 0.05M | -0.00M | ||||||||||||
| Selling, General & AdministrativeSG&A | 988.00 | 0.02M | 0.01M | 0.28M | 0.28M | 0.41M | 0.86M | 3.54M | 3.44M | 3.75M | 1.77M | 3.09M | 5.26M | 4.07M | 6.52M | 3.83M | 3.12M | |
| Operating ExpensesOpex | 988.00 | 0.02M | 0.01M | 0.28M | 0.28M | 0.41M | 0.86M | 3.59M | 3.49M | 3.80M | 1.77M | 3.18M | 5.32M | 4.06M | 6.52M | 3.83M | 3.12M | |
| Operating IncomeOp. Inc | -3.30M | -3.21M | -3.57M | -1.61M | -2.92M | -5.23M | -3.80M | -6.39M | -3.67M | -3.03M | ||||||||
| EBIT | -988.00 | -0.02M | -0.01M | 0.14M | 0.53M | 0.21M | 0.07M | -3.30M | -3.21M | -3.57M | -1.61M | -2.92M | -5.23M | -3.80M | -6.39M | -3.67M | -3.03M | |
| Non-operating items | ||||||||||||||||||
| Non Operating Interest Expenses | 0.07M | 0.07M | 0.01M | 0.16M | 8.49M | 0.21M | 0.69M | 5.12M | 0.24M | 0.20M | ||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.42M | 0.81M | 0.62M | 0.93M | 0.01M | 0.00M | 0.00M | 0.01M | 0.00M | 0.02M | 0.02M | 0.02M | 0.02M | 0.00M | ||||
| Other Non Operating IncomeOther Non Op Inc. | 0.03M | 0.03M | 0.08M | 0.00M | 0.03M | 0.22M | 0.02M | 4.12M | 0.00M | 1.80M | ||||||||
| Net income details | ||||||||||||||||||
| EBT | -988.00 | -0.02M | -0.01M | 0.14M | 0.53M | 0.21M | 0.07M | -3.36M | -3.25M | -3.50M | -1.79M | -11.39M | -5.23M | -4.49M | -7.78M | -3.92M | -1.44M | |
| Tax ProvisionsTaxes | 0.03M | 0.23M | 0.13M | 0.15M | 4.00 | -0.97M | -0.14M | -0.45M | -1.29M | -0.53M | -0.45M | -0.44M | ||||||
| Profit After TaxPAT | -988.00 | -0.02M | -0.01M | 0.11M | 0.30M | -0.41M | 1.37M | -3.36M | -2.28M | -3.36M | -1.34M | -11.39M | -5.23M | -5.45M | -7.25M | -3.47M | -4.16M | |
| Income from Non-Controlling InterestsInc. Minority | -5.56M | -1.82M | -2.42M | -1.54M | -2.89M | |||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -988.00 | -0.02M | -0.01M | 0.11M | 0.30M | 0.08M | -0.09M | -3.36M | -2.28M | -3.36M | -1.34M | -11.39M | -5.23M | -3.19M | -7.25M | -3.47M | -1.00M | |
| Consolidated Net IncomeConsol Net Inc. | -988.00 | -0.02M | -0.01M | 0.11M | 0.30M | 0.08M | -0.09M | -3.36M | -2.28M | -3.36M | -1.34M | -11.39M | -5.23M | -3.19M | -7.25M | -3.47M | -1.00M | |
| Income towards Parent CompanyParent Net Inc | -988.00 | -0.02M | -0.01M | 0.11M | 0.30M | 0.08M | -0.09M | -3.36M | -2.28M | -3.36M | -1.34M | -11.39M | -5.23M | -3.19M | -7.25M | -3.47M | -1.00M | |
| Net Income towards Common StockholdersNet Income | -988.00 | -0.02M | -0.01M | 0.11M | 0.30M | 0.08M | -0.09M | -3.36M | -2.28M | -3.36M | -1.34M | -11.39M | 0.33M | -2.13M | -4.82M | -2.93M | -0.85M | |
| Additional items | ||||||||||||||||||
| EPS (Basic) | 0.00 | -0.01 | -0.01 | 0.02 | 0.03 | 0.01 | -0.01 | -0.60 | -0.46 | -0.83 | -0.30 | -1.04 | 0.02 | -0.12 | -0.25 | -0.09 | -0.03 | |
| EPS (Diluted) | 0.00 | -0.01 | -0.01 | 0.02 | 0.03 | 0.01 | -0.01 | -0.60 | -0.46 | -0.83 | -0.30 | -1.04 | 0.02 | -0.09 | -0.21 | -0.09 | -0.03 | |
| Shares Outstanding | 1.50M | 1.50M | 1.50M | 1.50M | 5.23M | 9.05M | 9.05M | 7.69M | 5.62M | 4.95M | 4.04M | 4.48M | 10.91M | 15.16M | 17.38M | 19.52M | 31.21M | 32.89M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 1.50M | 1.50M | 1.50M | 5.23M | 9.05M | 9.05M | 7.72M | 5.62M | 4.95M | 4.04M | 4.48M | 10.91M | 16.09M | 23.12M | 22.56M | 34.27M | 33.39M | |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 1.73M | 1.50M | 9.09M | 9.09M | 9.09M | 9.05M | 9.05M | 7.69M | 9.09M | 11.25M | 4.04M | 4.48M | 18.25M | 18.25M | 17.38M | 19.81M | 31.21M | 32.89M |
| EBITDA | -988.00 | -0.02M | -0.01M | 0.14M | 0.53M | 0.21M | 0.07M | -3.30M | -3.21M | -3.57M | -1.61M | -2.92M | -5.23M | -3.80M | -6.39M | -3.67M | -3.03M | |
| Interest ExpensesInt Expense | 0.07M | 0.07M | 0.01M | 0.16M | 8.49M | 0.21M | 0.69M | 5.12M | 0.24M | 0.20M | ||||||||
| Tax Rate | 21.00% | 43.12% | 62.42% | 228.87% | 0.00% | 29.95% | 3.99% | 25.17% | 28.84% | 6.87% | 11.54% | 30.45% |